The ASCCP Guidelines provide evidence-based recommendations for cervical cancer screening, HPV testing, and management of abnormal results. Explore current algorithms, clinical updates, and …

The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide …

Discuss special populations and considerations for screening outside the typical screening. Apply management strategies for abnormal pap and HPV results by using the ASCCP application. …

• Allow updates to incorporate new test methods as they are validated, and to adjust for decreasing CIN3+ risks as more patients who received HPV vaccination reach screening age • Colposcopy …

No referral is required if they choose to access a specialist for these preventive services or if your office does not perform pelvic exams and Pap tests.

Risk-based Management Guidelines for abnormal screening results, including post-colposcopy or post-treatment scenarios. Enduring Guidelines apply this approach to new technologies that emerge and …

The American Society of Colposcopy and Cervical Pathology (ASCCP), has published their enduring consensus guidelines and now recognizes the use of p16/Ki-67 dual-stain biomarkers (CINtec® …

The revised guidelines provide a framework for incorporating new data and technologies as ongoing incremental recommendation revisions, minimizing the time needed to implement changes that are …

The guidelines were once again pub-lished in the Journal of Lower Genital Tract Disease, and the tables they reference are publicly available. Additionally, ASCCP is developing a new management …

Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) …